120 related articles for article (PubMed ID: 3309998)
1. Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Whiteside TL; Heo DS; Chen K; Adler A; Johnson JT; Herberman RB
Prog Clin Biol Res; 1987; 244():213-22. PubMed ID: 3309998
[No Abstract] [Full Text] [Related]
2. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
Grimm EA
Prog Clin Biol Res; 1987; 244():185-95. PubMed ID: 3498948
[No Abstract] [Full Text] [Related]
4. Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
Whiteside TL; Heo DS; Takagi S; Herberman RB
Transplant Proc; 1988 Apr; 20(2):347-50. PubMed ID: 2834838
[TBL] [Abstract][Full Text] [Related]
5. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
6. Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC).
Sondel PM; Hank JA; Rosenthal N; Moore KH; Hong R; Storer B; Kohler PC
Prog Clin Biol Res; 1987; 244():173-84. PubMed ID: 3498947
[No Abstract] [Full Text] [Related]
7. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
8. [Autologous lymphocytotoxicity against squamous cell carcinoma in head and neck. I. In vitro culture of squamous cell carcinoma in head and neck (author's transl)].
Ikawa T
Nihon Jibiinkoka Gakkai Kaiho; 1981 Dec; 84(12):1570-8. PubMed ID: 7341742
[No Abstract] [Full Text] [Related]
9. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
10. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
[No Abstract] [Full Text] [Related]
11. [Autologous lymphocytotoxicity against squamous cell carcinoma in head and neck. II. Evidence of autologous lymphocytotoxicity against tumor cell (author's transl)].
Ikawa T
Nihon Jibiinkoka Gakkai Kaiho; 1981 Dec; 84(12):1579-87. PubMed ID: 7341743
[No Abstract] [Full Text] [Related]
12. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
[TBL] [Abstract][Full Text] [Related]
13. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
14. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions.
Berlinger NT; Good RA
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999
[No Abstract] [Full Text] [Related]
15. The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.
Salter J; Maclennan KA; Moore J; Dadian G; Riches PG; Gore ME
J Pathol; 1995 Jun; 176(2):167-73. PubMed ID: 7636627
[TBL] [Abstract][Full Text] [Related]
16. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
[TBL] [Abstract][Full Text] [Related]
17. Production of lymphokine-activated lymphocytes. Lysis of human head and neck squamous cell carcinoma cell lines.
Alessi DM; Hutcherson RW; Mickel RA
Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):725-30. PubMed ID: 2785809
[TBL] [Abstract][Full Text] [Related]
18. [Study of head and neck cancer treatment by administration of autologous cytotoxic lymphocyte induced by stimulation with tumor cell--induction of killer cells by stimulation with allogeneic tumor cell].
Ikawa T; Ishikawa T; Eura M
Nihon Jibiinkoka Gakkai Kaiho; 1988 Dec; 91(12):2079-81. PubMed ID: 3266242
[No Abstract] [Full Text] [Related]
19. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Vujanovic NL; Yasumura S; Hirabayashi H; Lin WC; Watkins S; Herberman RB; Whiteside TL
J Immunol; 1995 Jan; 154(1):281-9. PubMed ID: 7995947
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis.
Damle NK; Doyle LV; Bender JR; Bradley EC
J Immunol; 1987 Mar; 138(6):1779-85. PubMed ID: 3493287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
